单位:[1]Chongqing Med Univ, Affiliated Hosp 1, Dept Crit Care Med, Chongqing, Peoples R China重庆医科大学附属第一医院[2]Huazhong Univ Sci & Technol,Tongji Hosp,Tongji Med Coll,Dept Crit Care Med,Wuhan,Peoples R China华中科技大学同济医学院附属同济医院急诊医学科
Coronavirus Disease 2019 (COVID-19) was first identified in China at the end of 2019. Acute respiratory distress syndrome (ARDS) represents the most common and serious complication of COVID-19. Cytokine storms are a pathophysiological feature of COVID-19 and play an important role in distinguishing hyper-inflammatory subphenotypes of ARDS. Accordingly, in this review, we focus on hyper-inflammatory host responses in ARDS that play a critical role in the differentiated development of COVID-19. Furthermore, we discuss inflammation-related indicators that have the potential to identify hyper-inflammatory subphenotypes of COVID-19, especially for those with a high risk of ARDS. Finally, we explore the possibility of improving the quality of monitoring and treatment of COVID-19 patients and in reducing the incidence of critical illness and mortality via better distinguishing hyperand hypo inflammatory subphenotypes of COVID-19. Copyright (C) 2020, Chongqing Medical University. Production and hosting by Elsevier B.V.
基金:
National Natural Science Foundation of China [81801894, 81873928]; High-level Medical Reserved Personnel Training Project of Chongqing